CV Sciences, Inc. (CVSI) › Shareholders' EquityCV Sciences, Inc. (CVSI) — Shareholders' EquityAnnual figures by period end, from SEC filings.2010-12-31: $22.7K2011-12-31: -$38.1K2012-12-31: -$692013-12-31: $8.31M2014-12-31: $21.08M2015-12-31: $23.29M2016-12-31: $13.21M2017-12-31: $16.38M2018-12-31: $30.12M2019-12-31: $29.15M2020-12-31: $11.21M2021-12-31: $3.54M2022-12-31: -$777.0K2023-12-31: $2.90M2024-12-31: $1.79M2025-12-31: $1.47M$1.47M2010-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$1.47M-18.2%2026-03-26Balance as of period end2024-12-31$1.79M-38.2%2026-03-26Balance as of period end2023-12-31$2.90M—2026-03-26Balance as of period end2022-12-31-$777.0K-121.9%2025-03-27Balance as of period end2021-12-31$3.54M-68.4%2024-03-29Balance as of period end2020-12-31$11.21M-61.5%2023-03-30Balance as of period end2019-12-31$29.15M-3.2%2022-04-04Balance as of period end2018-12-31$30.12M+83.8%2021-03-19Balance as of period end2017-12-31$16.38M+24.0%2020-03-30Balance as of period end2016-12-31$13.21M-43.3%2019-03-12Balance as of period end2015-12-31$23.29M+10.5%2018-03-30Balance as of period end2014-12-31$21.08M+153.7%2017-03-31Balance as of period end2013-12-31$8.31M—2016-04-14Balance as of period end2012-12-31-$69—2015-03-31Balance as of period end2011-12-31-$38.1K-268.0%2014-03-28Balance as of period end2010-12-31$22.7K—2013-04-16Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)